![Alexander Zukiwski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexander Zukiwski
Direttore Tecnico/Scientifico/R&S presso CASI PHARMACEUTICALS, INC.
Posizioni attive di Alexander Zukiwski
Società | Posizione | Inizio | Fine |
---|---|---|---|
CASI PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2017 | - |
Oncolyze, Inc.
![]() Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Alexander Zukiwski
Precedenti posizioni note di Alexander Zukiwski
Società | Posizione | Inizio | Fine |
---|---|---|---|
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Direttore Tecnico/Scientifico/R&S | 05/11/2007 | 01/03/2011 |
Ortho Biotech, Inc. | Corporate Officer/Principal | - | - |
Centocor Research & Development, Inc. | Corporate Officer/Principal | - | - |
Johnson & Johnson Pharmaceutical Research & Development LLC
![]() Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Pharmaceutical Research & Development LLC provides research and development support services. It offers drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. The company is headquartered in Raritan, NJ. | Corporate Officer/Principal | - | - |
CASI Pharmaceuticals, Inc. /Old/
![]() CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Direttore Tecnico/Scientifico/R&S | 01/04/2017 | - |
ARNO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 02/12/2014 | - |
Amministratore Delegato | 18/07/2014 | - | |
Direttore Tecnico/Scientifico/R&S | 29/06/2011 | - | |
Presidente | 02/12/2014 | - | |
AMBIT BIOSCIENCES CORP | Direttore/Membro del Consiglio | - | - |
░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Alexander Zukiwski
University of Alberta | Undergraduate Degree |
University of Calgary | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Canada | 3 |
Isole Cayman | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 4 |
Director/Board Member | 3 |
Settori
Health Technology | 8 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
JOHNSON & JOHNSON | Health Technology |
ARNO THERAPEUTICS, INC. | Health Technology |
CASI PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 7 |
---|---|
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Ambit Biosciences Corp.
![]() Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
CASI Pharmaceuticals, Inc. /Old/
![]() CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
Johnson & Johnson Pharmaceutical Research & Development LLC
![]() Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Pharmaceutical Research & Development LLC provides research and development support services. It offers drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. The company is headquartered in Raritan, NJ. | Commercial Services |
Centocor Research & Development, Inc. | |
Ortho Biotech, Inc. | |
Oncolyze, Inc.
![]() Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Alexander Zukiwski
- Esperienza